Advanced search×

Cost-effectiveness of implantable defibrillators after myocardial infarction based on 8-year follow-up data (MADIT II).

Afschin A Gandjour, Astrid A Holler, Dipl-Ges-Ök, and Charles Christian CC Adarkwah

Value Health 14(6):812-7 (2011) PMID 21914500

About 190,000 Germans experience a myocardial infarction each year. Of these, 25% may be eligible for an implantable cardioverter defibrillator (ICD) due to low left ventricular ejection fraction. Given the high costs of implantation, the purpose of this study was to assess the cost-effectiveness of ICDs compared to conventional therapy in patients with an ejection fraction 30% or less after MI in Germany.

DOI: 10.1016/j.jval.2011.02.1180
Version: za2963e q8za0 q8zb6 q8zc9 q8zd4 q8zef q8zff q8zgc

Similar articles you may find interesting…

  1. Development of a predictive model for long-term survival after lung transplantation and implications for the lung allocation score
    Cynthia J Gries, Tessa C Rue, ... Christopher H Goss

    J Heart Lung Transplant 29(7):8 (2010) PMID 20382034

    Models developed from pre-transplant characteristics poorly predict long-term survival. Models for separate diseases and 1-year conditional models did not improve prediction. Better databases and approaches to predict survival are needed to improve lung allocation....
  2. Certolizumab pegol compared to natalizumab in patients with moderate to severe Crohn's disease: results of a decision analysis.
    Ashwin N AN Ananthakrishnan, Chin C Hur, and Joshua R JR Korzenik

    Dig Dis Sci 57(2):472-80 (2012) PMID 21909990

    In patients with moderate to severe CD failing two TNF-antagonists, using a third TNF-antagonist therapy appears to be a cost-effective strategy without significantly compromising treatment efficacy....